Sylvester breaks ground on Transformational Cancer Research Building to accelerate new cures
Sylvester Comprehensive Cancer Center, part of UHealth-University of Miami Health System and the only cancer center in South Florida to be ranked by U.S. News & World Report 2022-2023 Best Hospitals for Cancer, continues to be at the forefront of cancer care and research. In June, they celebrated the groundbreaking of the 244,000-square-foot, state-of-the-art Sylvester Comprehensive Cancer Center-Transformational Cancer Research Building (TCRB). Slated to open in 2024, the 12-story facility on Sylvester's downtown Miami campus will be a unique hub for cancer research, innovation, wellness, and patient-centered care, all under one roof.
"As one of only two centers in Florida designated by the National Cancer Institute, our mission is to pioneer groundbreaking cancer research, innovate, and advance cancer cures. To fulfill this mission, Sylvester is constructing a premier cancer research facility that will bring hope to patients in Florida and beyond," said Stephen D. Nimer, M.D., director of Sylvester Comprehensive Cancer Center.
The TCRB will be an ultra-modern patient care and research facility to support new and emerging directions in cancer treatment. It will be a center specially designed to expand breakthrough discoveries and be a magnet for attracting the most accomplished researchers to tackle the world's toughest-to-treat cancers.
As explained by Dr. Nimer, the goal is to bring together technology, luminary research, and cross-disciplinary partnerships to create a central location for cancer care innovation. "We will leverage Miami's significant rise in the technology sector to harness the power of state-of-the- art equipment and laboratories as well as the latest network and machine-learning technologies to accelerate the translation of scientific discoveries into life-saving and practice-changing treatments and therapies for patients in Florida, and share these transformative results with patients, providers, and cancer centers worldwide," he said.
Wellness and survivorship also will be a focal point of the new building, emphasizing total-body wellness during cancer treatment to improve quality of life. It will set the standard for survivorship programs that prioritize recurrence prevention to benefit patients and their families.
From deploying highly targeted therapies with personalized medicine to unlocking mRNA technology for fighting diseases, the unmatched resources at the TCRB will advance Sylvester's capabilities to care for patients. Leveraging cutting-edge imaging, multidisciplinary collaborations, and dynamic physical space with two floors dedicated to patient care, the TCRB will expand Sylvester's pursuit of cancer cures. This space also will provide a larger home for Sylvester's Phase 1 Clinical Trials Program, one of the only such programs in the region, to offer trials rarely available anywhere else. To learn more, visit TheSylvesterPursuit.org.